Results 271 to 280 of about 5,711,473 (427)
Innovation leadership perspective in public health. [PDF]
Chibi M, Galea G.
europepmc +1 more source
Policy-mix and SME innovation: Evidence from China. [PDF]
Zhao K, Shan H, Gao Y.
europepmc +1 more source
Mitochondrial DNA disorders in neuromuscular diseases in diverse populations
Abstract Neuromuscular features are common in mitochondrial DNA (mtDNA) disorders. The genetic architecture of mtDNA disorders in diverse populations is poorly understood. We analysed mtDNA variants from whole‐exome sequencing data in neuromuscular patients from South Africa, Brazil, India, Turkey and Zambia. In 998 individuals, there were two definite
Fei Gao+34 more
wiley +1 more source
How can ethical leadership increase employees' bootlegging innovation behavior in China?: a serial mediation model of psychological wellbeing and psychological entitlement. [PDF]
Zhang J, Choi M, Wang K, Kim HE.
europepmc +1 more source
Abstract Objectives An increasing body of evidence indicates altered DNA methylation in Parkinson's disease, yet the reproducibility and utility of such methylation changes are largely unexplored. We aimed to further elucidate the role of dysregulated DNA methylation in Parkinson's disease and to evaluate the biomarker potential of methylation‐based ...
Ingeborg Haugesag Lie+4 more
wiley +1 more source
Exploring the new model of medical innovation and entrepreneurship talent training based on biodesign in eastern China. [PDF]
Chenchen X+8 more
europepmc +1 more source
Abstract Objective We measured clinical and quantitative MRI outcome measures in CMT1A to assess long‐term responsiveness, establish longitudinal validity and assess MRI as a bridging biomarker. Methods Twenty patients with CMT1A and 20 matched controls underwent MRI, myometry and clinical assessments up to four times over mean 4‐year follow‐up ...
Matthew R. B. Evans+8 more
wiley +1 more source